Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -7.53% | -0.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -7.53% | -0.22% | |||
| Cost of Revenue | -4.39% | -2.73% | |||
| Gross Profit | -9.77% | 1.66% | |||
| SG&A Expenses | -12.47% | 17.85% | |||
| Depreciation & Amortization | 3.60% | 0.72% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.52% | 3.99% | |||
| Operating Income | -28.81% | -30.18% | |||
| Income Before Tax | -57.14% | -35.63% | |||
| Income Tax Expenses | 200.00% | -93.33% | |||
| Earnings from Continuing Operations | -66.67% | -5.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -66.67% | -5.26% | |||
| EBIT | -28.81% | -30.18% | |||
| EBITDA | -9.89% | -15.52% | |||
| EPS Basic | -66.70% | -5.59% | |||
| Normalized Basic EPS | -58.43% | -37.12% | |||
| EPS Diluted | -66.70% | -1.73% | |||
| Normalized Diluted EPS | -58.53% | -36.87% | |||
| Average Basic Shares Outstanding | 0.04% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.12% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||